These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 177782)

  • 1. Inhibition of separated forms of phosphodiesterases from pig coronary arteries by uracils and by 7-substituted derivatives of 1-methyl-3-isobutylxanthine.
    Garst JE; Kramer GL; Wu YJ; Wells JN
    J Med Chem; 1976 Apr; 19(4):499-503. PubMed ID: 177782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from pig coronary arteries by 1,3-disubstituted and 1,3,8-trisubstituted xanthines.
    Wells JN; Garst JE; Kramer GL
    J Med Chem; 1981 Aug; 24(8):954-8. PubMed ID: 6276544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms.
    Keravis TM; Wells JN; Hardman JG
    Biochim Biophys Acta; 1980; 613(1):116-29. PubMed ID: 6246952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylxanthine inhibitors of phosphodiesterases.
    Wells JN; Miller JR
    Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
    Miot F; Erneux C; Wells JN; Dumont JE
    Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of cyclic nucleotide phosphodiesterases by analogues of 1-methyl-3-isobutylxanthine.
    Kramer GL; Garst JE; Mitchel SS; Wells JN
    Biochemistry; 1977 Jul; 16(15):3316-21. PubMed ID: 196632
    [No Abstract]   [Full Text] [Related]  

  • 7. The adnosine 3',5'-monophosphate and guanosine 3',5'-monophosphate phosphodiesterases from human lung tissue.
    Green D; Guy G; Moore JB
    Life Sci; 1977 Apr; 20(7):1157-62. PubMed ID: 191714
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic nucleotide phosphodiesterase activities of pig coronary arteries.
    Wells JN; Baird CE; Hardman YJ; Wu JG
    Biochim Biophys Acta; 1975 Apr; 384(2):430-42. PubMed ID: 164919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclic nucleotide phosphodiesterases from pig coronary artery by benzo-separated analogues of 3-isobutyl-1-methylxanthine.
    Schneller SW; Ibay AC; Martinson EA; Wells JN
    J Med Chem; 1986 Jun; 29(6):972-8. PubMed ID: 2423691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
    Azhar S; Menon KM
    Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trapidil derivatives as potent inhibitors of cyclic AMP phosphodiesterase from heart and coronary arteries.
    Bartel S; Tenor H; Krause EG
    Biomed Biochim Acta; 1985; 44(5):K31-5. PubMed ID: 2415118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterases from porcine coronary arteries: inhibition of separated forms by xanthines, papaverine, and cyclic nucleotides.
    Wells JN; Wu YJ; Baird CE; Hardman JG
    Mol Pharmacol; 1975 Nov; 11(6):775-83. PubMed ID: 173982
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM; Butcher RW
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE; Lakey T; Houslay MD
    Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-Substituted derivatives of adenosine 3',5'-cyclic phosphate require an unsubstituted 2'-hydroxyl group in the ribo configuration for biological activity.
    Khwaja TA; Boswell KH; Robins RK; Miller JP
    Biochemistry; 1975 Sep; 14(19):4238-44. PubMed ID: 170958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of xanthine-induced relaxation of guinea-pig isolated trachealis muscle.
    Ogawa K; Takagi K; Satake T
    Br J Pharmacol; 1989 Jun; 97(2):542-6. PubMed ID: 2547475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective tracheal relaxation and phosphodiesterase-IV inhibition by xanthine derivatives.
    Miyamoto K; Kurita M; Ohmae S; Sakai R; Sanae F; Takagi K
    Eur J Pharmacol; 1994 May; 267(3):317-22. PubMed ID: 8088370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of beef cortex membrane-bound 3', 5'-AMP phosphodiesterase by halogenated purines.
    Macdonald IA
    Pharmacol Res Commun; 1977 Jan; 9(1):49-58. PubMed ID: 194263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.